1.
Glasmacher A, Goldschmidt H, Mezger J, Haferlach T, Schmidt-Wolf I, Gieseler F, Phase II trial. Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trial. Haematologica 2004; 89(3):371-373.